The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pharmaceutical Contract Development and Manufacturing-Global Market Insights and Sales Trends 2025
Synopsis
The global Pharmaceutical Contract Development and Manufacturing market size is expected to reach US$ 188680 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Contract Development and Manufacturing in various end use industries. The expanding demands from the Big Pharma, Small Pharma, Generic Pharma and CRO, are propelling Pharmaceutical Contract Development and Manufacturing market. Pharmaceutical Manufacturing Services, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biologics Manufacturing Services segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Contract Development and Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Contract Development and Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Contract Development and Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Contract Development and Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Contract Development and Manufacturing covered in this report include Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GMBH, FAMAR Health Care Services, AbbVie Inc., Aenova Group and Consort Medical plc, etc.
The global Pharmaceutical Contract Development and Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific Inc.
Catalent, Inc.
Lonza Group Ltd
Recipharm AB
Vetter Pharma International GMBH
FAMAR Health Care Services
AbbVie Inc.
Aenova Group
Consort Medical plc
Almac Group
Siegfried Holding AG
Boehringer Ingelheim International GmbH
Evonik Industries AG
Global Pharmaceutical Contract Development and Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Contract Development and Manufacturing market, Segment by Type:
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services
Global Pharmaceutical Contract Development and Manufacturing market, by Application
Big Pharma
Small Pharma
Generic Pharma
CRO
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Contract Development and Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Pharmaceutical Contract Development and Manufacturing market size is expected to reach US$ 188680 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Contract Development and Manufacturing in various end use industries. The expanding demands from the Big Pharma, Small Pharma, Generic Pharma and CRO, are propelling Pharmaceutical Contract Development and Manufacturing market. Pharmaceutical Manufacturing Services, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biologics Manufacturing Services segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Contract Development and Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Contract Development and Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Contract Development and Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Contract Development and Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Contract Development and Manufacturing covered in this report include Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GMBH, FAMAR Health Care Services, AbbVie Inc., Aenova Group and Consort Medical plc, etc.
The global Pharmaceutical Contract Development and Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific Inc.
Catalent, Inc.
Lonza Group Ltd
Recipharm AB
Vetter Pharma International GMBH
FAMAR Health Care Services
AbbVie Inc.
Aenova Group
Consort Medical plc
Almac Group
Siegfried Holding AG
Boehringer Ingelheim International GmbH
Evonik Industries AG
Global Pharmaceutical Contract Development and Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Contract Development and Manufacturing market, Segment by Type:
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services
Global Pharmaceutical Contract Development and Manufacturing market, by Application
Big Pharma
Small Pharma
Generic Pharma
CRO
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Contract Development and Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pharmaceutical Contract Development and Manufacturing
1.1 Pharmaceutical Contract Development and Manufacturing Market Overview
1.1.1 Pharmaceutical Contract Development and Manufacturing Product Scope
1.1.2 Pharmaceutical Contract Development and Manufacturing Market Status and Outlook
1.2 Global Pharmaceutical Contract Development and Manufacturing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmaceutical Contract Development and Manufacturing Market Size by Region (2018-2029)
1.4 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Region (2018-2023)
1.5 Global Pharmaceutical Contract Development and Manufacturing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmaceutical Contract Development and Manufacturing Market Size (2018-2029)
1.6.1 North America Pharmaceutical Contract Development and Manufacturing Market Size (2018-2029)
1.6.2 Europe Pharmaceutical Contract Development and Manufacturing Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size (2018-2029)
1.6.4 Latin America Pharmaceutical Contract Development and Manufacturing Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size (2018-2029)
2 Pharmaceutical Contract Development and Manufacturing Market by Type
2.1 Introduction
2.1.1 Pharmaceutical Manufacturing Services
2.1.2 Biologics Manufacturing Services
2.1.3 Drug Development Services
2.2 Global Pharmaceutical Contract Development and Manufacturing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Type (2018-2023)
2.2.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmaceutical Contract Development and Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmaceutical Contract Development and Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmaceutical Contract Development and Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue Breakdown by Type (2018-2029)
3 Pharmaceutical Contract Development and Manufacturing Market Overview by Application
3.1 Introduction
3.1.1 Big Pharma
3.1.2 Small Pharma
3.1.3 Generic Pharma
3.1.4 CRO
3.2 Global Pharmaceutical Contract Development and Manufacturing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Application (2018-2023)
3.2.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmaceutical Contract Development and Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmaceutical Contract Development and Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmaceutical Contract Development and Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue Breakdown by Application (2018-2029)
4 Pharmaceutical Contract Development and Manufacturing Competition Analysis by Players
4.1 Global Pharmaceutical Contract Development and Manufacturing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2022)
4.3 Date of Key Players Enter into Pharmaceutical Contract Development and Manufacturing Market
4.4 Global Top Players Pharmaceutical Contract Development and Manufacturing Headquarters and Area Served
4.5 Key Players Pharmaceutical Contract Development and Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmaceutical Contract Development and Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific Inc.
5.1.1 Thermo Fisher Scientific Inc. Profile
5.1.2 Thermo Fisher Scientific Inc. Main Business
5.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Inc. Recent Developments
5.2 Catalent, Inc.
5.2.1 Catalent, Inc. Profile
5.2.2 Catalent, Inc. Main Business
5.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.2.4 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.2.5 Catalent, Inc. Recent Developments
5.3 Lonza Group Ltd
5.3.1 Lonza Group Ltd Profile
5.3.2 Lonza Group Ltd Main Business
5.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.3.4 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.3.5 Recipharm AB Recent Developments
5.4 Recipharm AB
5.4.1 Recipharm AB Profile
5.4.2 Recipharm AB Main Business
5.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.4.4 Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.4.5 Recipharm AB Recent Developments
5.5 Vetter Pharma International GMBH
5.5.1 Vetter Pharma International GMBH Profile
5.5.2 Vetter Pharma International GMBH Main Business
5.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.5.4 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.5.5 Vetter Pharma International GMBH Recent Developments
5.6 FAMAR Health Care Services
5.6.1 FAMAR Health Care Services Profile
5.6.2 FAMAR Health Care Services Main Business
5.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.6.4 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.6.5 FAMAR Health Care Services Recent Developments
5.7 AbbVie Inc.
5.7.1 AbbVie Inc. Profile
5.7.2 AbbVie Inc. Main Business
5.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.7.4 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.7.5 AbbVie Inc. Recent Developments
5.8 Aenova Group
5.8.1 Aenova Group Profile
5.8.2 Aenova Group Main Business
5.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.8.4 Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.8.5 Aenova Group Recent Developments
5.9 Consort Medical plc
5.9.1 Consort Medical plc Profile
5.9.2 Consort Medical plc Main Business
5.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.9.4 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.9.5 Consort Medical plc Recent Developments
5.10 Almac Group
5.10.1 Almac Group Profile
5.10.2 Almac Group Main Business
5.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.10.4 Almac Group Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.10.5 Almac Group Recent Developments
5.11 Siegfried Holding AG
5.11.1 Siegfried Holding AG Profile
5.11.2 Siegfried Holding AG Main Business
5.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.11.4 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.11.5 Siegfried Holding AG Recent Developments
5.12 Boehringer Ingelheim International GmbH
5.12.1 Boehringer Ingelheim International GmbH Profile
5.12.2 Boehringer Ingelheim International GmbH Main Business
5.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.12.4 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.12.5 Boehringer Ingelheim International GmbH Recent Developments
5.13 Evonik Industries AG
5.13.1 Evonik Industries AG Profile
5.13.2 Evonik Industries AG Main Business
5.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Products, Services and Solutions
5.13.4 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue (US$ Million) & (2018-2023)
5.13.5 Evonik Industries AG Recent Developments
6 North America
6.1 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmaceutical Contract Development and Manufacturing Market Dynamics
11.1 Pharmaceutical Contract Development and Manufacturing Industry Trends
11.2 Pharmaceutical Contract Development and Manufacturing Market Drivers
11.3 Pharmaceutical Contract Development and Manufacturing Market Challenges
11.4 Pharmaceutical Contract Development and Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
